France Officially Sanctions Drug After 78 Of 80 Patients

New Post Public Reply Private Reply Replies (2) Message Board
wowhappens28
121
France Officially Sanctions Drug After 78 Of 80 Patients Recover From COVID-19 Within Five Days

Despite What The Media Says, Trump Was RIGHT — Chloroquine Treatments Having Tremendous Results On French Patients

“The French government has officially sanctioned prescriptions of chloroquine to treat certain coronavirus patients,” France 24 English reported Saturday.

“This ensures continued treatment of patients who have been treated for several years for a chronic condition with this drug, but also allows a temporary authorization to allow certain patients with coronavirus to benefit from this therapeutic route,” said France’s director general of health Jérôme Salomon.

The move comes after infectious diseases specialist Didier Raoult announced new clinical results, which can be accessed here, that show 78 out of 80 patients treated with chloroquine recovered within five days, reported Trustnodes.

The five-day recovery time is “considerably” faster “than the usual 14 days and for some it can go up to 28 days if they recover at all,” the outlet highlighted.

France’s Minister of Health Olivier Véran said Thursday: “Hydroxychloroquine and the combination of lopinavir / ritonavir may be prescribed, dispensed and administered under the responsibility of a doctor to patients affected by Covid-19, in the healthcare establishments which take charge of them, as well as for the continuation of their treatment if their condition allows it and with the authorization of the initial prescriber, at home.”

Dr. Raouly cheered the news via social media on Saturday: “Thanks to Philippe Douste-Blazy, former Minister of Health and member of the Board of Directors of the @IHU_Marseille, for his position,” he wrote.

Merci à Philippe Douste-Blazy, ancien Ministre de la Santé et membre du Conseil d'Administration de l'@IHU_Marseille, pour sa prise de position.https://www.youtube.com/watch?time_continue=1&v=wBZjLq0aB58&feature=emb_title …

Due to President Donald Trump fast-tracking Food and Drug Administration approval, New York state is testing hydroxychloroquine, chloroquine and azithromycin.

“The Food and Drug Administration has moved with ‘uncommon speed’ to authorize New York’s distribution of the drugs through hospitals,” The Daily Wire noted Thursday, citing a Washington Post report. “While experts say such an effort would usually take up to nine months, the timeline ‘has been compressed into three days,’ the paper reports.”

As highlighted by The Daily Wire, positive results from the drugs have thus far been largely anecdotal:

The Times repeatedly underscores that the treatment has not yet been proven to be effective by officials and highlights “concerns” among health experts about the Trump and Cuomo-promoted medications, which sometimes have dangerous side effects, like “fatal heart arrhythmia and vision loss.” Like The Washington Post’s editorial board, which has accused Trump of causing “damage” by pointing to the treatment as a potential “cure,” the Times suggests Trump, and to a lesser extent Cuomo, may be guilty of “raising false hopes in the American public” and “contribut[ing] to runs on supply and hoarding” of the drugs.

Adding to the anecdotal evidence, “Lost” actor Daniel Dae Kim said hydroxychloroquine was the “secret weapon” that helped him recover from coronavirus.

“And here’s what I consider to be the secret weapon: hydroxychloroquine,” Kim said in a video posted to social media, last week. “This is a common anti-malarial drug that has been used with great success in Korea in their fight against the coronavirus. And yes, this is the drug that the president mentioned the other day.”

Kim similarly underscored that Dr. Anthony Fauci has “cautioned” against hydroxychloroquine,” noting that evidence of its effectiveness against COVID-19 is “anecdotal.”

“That is correct … it is only based on personal accounts,” he stressed. “Well, add my name to those personal accounts, because I am feeling better.”

https://www.dailywire.com/news/france-officia...-five-days
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Community Heritage Financial Declares Q3 2026 Dividend

Updated Category News Views 6

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Continue Reading
New JPA Aims to Energize Inland Empire's Water Supply

Updated Category News Views 25

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

Continue Reading
Baidu Faces Class Action: Investors Push Against Fraud Allegations

Updated Category News Views 13

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Continue Reading
Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 16

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 7

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 9

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
National Showrooms Expands into Virginia with Key Buy

Updated Category News Views 8

A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Roof Inspections: Richmond's Key to Home Longevity

Updated Category News Views 13

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

Continue Reading
VISTAR Oakland Workers Join Teamsters for Unity

Updated Category News Views 10

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Continue Reading

Top 5 Most Recently Viewed Articles

Silicom's High-Speed NICs Chosen for New Testing Solutions

Updated Category News Views 179

Silicom's Latest Milestone in Networking Solutions Silicom Ltd. (NASDAQ: SILC), a prominent name in the realm of networking and data infrastructure solutions, is making headlines with its selection by a notable client in the network testing equipment industry. This collaboration marks a significant step forward as Silicom's high-performance 100 gigabit Network Interface...

Continue Reading
Marvell Technology Positions for AI Growth with Strategic Sale

Updated Category News Views 155

Marvell Technology Takes Bold Step with $2.5 Billion Sale Marvell Technology Inc. (NASDAQ: MRVL) has made headlines with the strategic sale of its automotive Ethernet business for an impressive $2.5 billion. This all-cash transaction signifies Marvell's commitment to strengthening its position within the expanding data center and artificial intelligence landscapes....

Continue Reading
New Leadership at EyeCool Therapeutics Enhances Product Potential

Updated Category News Views 115

EyeCool Therapeutics Welcomes Dr. Vance Thompson EyeCool Therapeutics, a pioneering force in the medical device sector, is excited to announce that Dr. Vance Thompson has joined its board of directors. This strategic appointment marks a significant step as the company develops solutions aimed at chronic ocular pain, an area that is often overlooked in conventional...

Continue Reading
Azerion Leadership Enhances Company Trust Through Share Acquisitions

Updated Category News Views 125

Leadership Team Shows Confidence in Azerion Azerion has recently informed stakeholders about significant share purchases being made by members of its Executive Committee, alongside other operational leaders. This proactive approach illustrates the leadership's solid belief in the company's strategic vision and its potential for substantial growth. Such actions are aimed...

Continue Reading
Cyngn Sees Significant Growth in Autonomous Vehicle Orders

Updated Category News Views 105

Cyngn’s Remarkable Growth in Vehicle Orders MOUNTAIN VIEW, Calif. — Cyngn has announced a staggering increase in the number of DriveMod Tuggers sold, tripling its sales in the previous year. This significant growth not only reflects the surging demand for autonomous vehicles but also highlights the expansion of operational activities among various enterprises....

Continue Reading